Anyone following the debate on childhood transition knows that voicing concerns about the early transitioning approach translates to an uphill battle. It’s a battle fought every step of the way and an access point to the joyful cycle of being harassed and defamed.

Much to my surprise, however, a new paper published by a prestigious journal, the Lancet Child & Adolescent Health, urges greater caution regarding the use of puberty blockers. The paper was written in response to an editorial published by the journal earlier this year. That editorial opposed recent initiatives banning gender-affirming care in children under 18.